Investment Thesis Report: Decentralized Clinical Trials

Clinical trial sites are exploring new technology innovations to simplify and fix the many challenges faced by clinical trials today. Advanced technology for clinical trials would lead to many benefits, including faster recruitment, higher patient retention rates due to improved patient experience, advanced data collection, and virtual patient observation. Perhaps the most valuable benefit from advancing technology, however, is the implementation of decentralized clinical trials, clinical trials executed through telemedicine and technology different from the traditional clinical trial model.

Read More
Investment Thesis Report: Generative AI

The increasing attention of AI in corporate communications and rising public interest make clear that AI in healthcare is not just a transient trend but a necessity for a more efficient, personalized, and accessible future. As AI becomes integrated into more healthcare processes, it is critical to maintain a focus on patient safety by creating regulatory policies to maintain integrity and ensure accurate data. 

Read More
Independence Blue Cross teams up with Carallel to give caregivers a support system

SafeRide Health, the leading technology-first platform connecting patients to life sustaining care, announced today the close of their Series B. SafeRide’s Series B is led by Sands Capital, a global asset manager with over $80 billion under management, with additional participation from new investors Seminal Capital, Hill City Capital, Fry’s Path Capital and Primetime Partners, as well as existing investors Fresenius Medical Ventures, Bonfire Ventures and Meridian Street Capital.

Read More
SafeRide Health Announces Series B Funding to Transform Access to Care

SafeRide Health, the leading technology-first platform connecting patients to life sustaining care, announced today the close of their Series B. SafeRide’s Series B is led by Sands Capital, a global asset manager with over $80 billion under management, with additional participation from new investors Seminal Capital, Hill City Capital, Fry’s Path Capital and Primetime Partners, as well as existing investors Fresenius Medical Ventures, Bonfire Ventures and Meridian Street Capital.

Read More
Vivante Health Closes $31 Million Series B Round to Advance Digital Digestive Health Platform

Vivante Health, the leader in digital digestive health, today announced the closing of $31 million in Series B funding led by new investor Mercato Partners. The round also includes new capital from Health Catalyst Capital as well as returning investors 7wireVentures, Intermountain Ventures, Distributed Ventures, Human Capital, and SemperVirens.

Read More
Intrinsic Evolves Into Women's Health-Centric CPG with $15 Million in New Funding 

Intrinsic, an omni-channel consumer health company, today announced a $15 million equity fundraise to focus exclusively on women's health. The new capital, which brings the company's total funding to $128 million raised to date, includes participation from new investors FCA Venture Partners and MAP Investco, along with existing investors Define Ventures, Link Ventures, Redesign Health, and others.

Read More